Education
About Us
Working with TipRanks
Follow Us
Panacea Life Sciences Holdings Inc (PLSH)
:PLSH
Total Valuation
Panacea Life Sciences Holdings Inc has a market cap or net worth of $1.22M. The enterprise value is ―.
Market Cap$1.22M
Enterprise Value―
Share Statistics
Panacea Life Sciences Holdings Inc has 20,261,288 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding20,261,288
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Panacea Life Sciences Holdings Inc’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is -39.38%.
Return on Equity (ROE)0.07
Return on Assets (ROA)-0.05
Return on Invested Capital (ROIC)-39.38%
Return on Capital Employed (ROCE)0.60
Revenue Per Employee102.69K
Profits Per Employee-14.58K
Employee Count40
Asset Turnover0.37
Inventory Turnover0.34
Valuation Ratios
The current PE Ratio of Panacea Life Sciences Holdings Inc is 0.5. Panacea Life Sciences Holdings Inc’s PEG ratio is 0.00846.
PE Ratio0.5
PS Ratio0.11
PB Ratio-0.06
Price to Fair Value-0.06
Price to FCF0.67
Price to Operating Cash Flow0.75
PEG Ratio0.00846
Income Statement
In the last 12 months, Panacea Life Sciences Holdings Inc had revenue of 4.11M and earned -583.20K in profits. Earnings per share was -0.03.
Revenue4.11M
Gross Profit2.85M
Operating Income-2.58M
Pretax Income-583.20K
Net Income-583.20K
EBITDA2.39M
Earnings Per Share (EPS)-0.03
Cash Flow
In the last 12 months, operating cash flow was 1.61M and capital expenditures 5.00K, giving a free cash flow of 1.62M billion.
Operating Cash Flow1.61M
Free Cash Flow1.62M
Free Cash Flow per Share0.08
Dividends & Yields
Panacea Life Sciences Holdings Inc pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.90
52-Week Price Change-40.00%
50-Day Moving Average0.06
200-Day Moving Average0.05
Relative Strength Index (RSI)46.45
Average Volume (3m)6.56K
Important Dates
Panacea Life Sciences Holdings Inc upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Panacea Life Sciences Holdings Inc as a current ratio of 0.35, with Debt / Equity ratio of -114.18%
Current Ratio0.35
Quick Ratio0.11
Debt to Market Cap31.20
Net Debt to EBITDA5.56
Interest Coverage Ratio-1.41
Taxes
In the past 12 months, Panacea Life Sciences Holdings Inc has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Panacea Life Sciences Holdings Inc EV to EBITDA ratio is 5.76, with an EV/FCF ratio of 20.01.
EV to Sales3.36
EV to EBITDA5.76
EV to Free Cash Flow20.01
EV to Operating Cash Flow20.01
Balance Sheet
Panacea Life Sciences Holdings Inc has $242.53K in cash and marketable securities with $11.33M in debt, giving a net cash position of -$11.09M billion.
Cash & Marketable Securities$242.53K
Total Debt$11.33M
Net Cash-$11.09M
Net Cash Per Share-$0.55
Tangible Book Value Per Share-$0.55
Margins
Gross margin is 71.57%, with operating margin of -62.71%, and net profit margin of -14.20%.
Gross Margin71.57%
Operating Margin-62.71%
Pretax Margin-14.20%
Net Profit Margin-14.20%
EBITDA Margin58.30%
EBIT Margin30.24%
Analyst Forecast
The average price target for Panacea Life Sciences Holdings Inc is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―